Top 5 Malaysia Stocks Traded on POEMS in September 2020 October 16, 2020
Here are September’s top 5 traded Malaysian stocks on Phillip’s Online Electronic Mart System (POEMS), based on gross market values traded. We hope the list will give you a view of one of Malaysia’s top-performing sectors – the glove sector – as we expect continued demand for rubber gloves as the pandemic rages on.
From the 5th position up are:
5th: Bintai Kinden Corp Berhad (BURSA: 6998)
Source: Bloomberg
Bintai Kinden specialises in mechanical and electrical engineering services. These include instrumentation, building automation and other multi-discipline industrial services1.
In August 2020, Bintai Kinden signed a memorandum of understanding with Institut Jantung Negara (IJN) to collaborate in the commercial development of a COVID-19 vaccine, based on Bintai Kinden’s existing partnership with US biotech firm, Generex Biotechnology Corp [GNBT.US]. The agreement is for the development, manufacturing and commercial registration of Generex’s COVID-19 vaccine. This vaccine is currently in the pre-clinical stage of development. It is pending approval from the US FDA, before moving on to human clinical trials and manufacturing.
If the commercial development is successful, Bintai Kinden could be the first to introduce a COVID-19 vaccine in Malaysia. Its share price reflects investors’ expectations, increasing 491% YTD to RM0.68.
4th: Iris Corporation Berhad (BURSA: 0010)
Source: Bloomberg
Iris provides technology consultation services, hardware and software to airlines and airports for their security systems. Its share price has jumped by 100% YTD, to a high of RM0.435 on 6 August 20203.
In September, Iris signed a Letter of Intent (LOI) with the India Security Press for the supply of RM15mn electronic contactless inlays and operating systems. These will be used for making Indian e-passports that are International Civil Aviation Organization-compliant. Worth US$27.54mn, the deal is expected to propel Iris to the global stage for e-passport production4.
3rd: JCY International Berhad (BURSA: 5161)
Source: Bloomberg
Coming third was JCY International, a leading component supplier and contract manufacturer of data storage in Malaysia. Revenue in Q1 2020 climbed 4% YoY5 and share price has increased more than 160% YTD6.
The reason? Movement control in Malaysia bumped up demand for personal computers and laptops for use at home. This in turn jacked up demand for hard disk drives. We can expect the momentum to continue as work-from-home arrangements become the norm.
2nd: Supermax Corporation Berhad (BURSA: 7106)
Source: Bloomberg
Supermax, a leading Malaysian latex-glove maker, produces over 24bn pieces of gloves per year and exports to more than 160 countries. Revenue in Q2 2020 was up 38.59% from 2019 levels8.
COVID-19 has created unprecedented demand for personal protection equipment (PPE), especially latex gloves, from almost all sectors. Reflecting this, Supermax’s share price has jumped over 1,000% YTD! As COVID-19 cases continue to spike, further demand and sales of latex gloves are expected9.
1st: TopGlove Corporation Berhad (BURSA: 7113)
Source: Bloomberg
Finally, dual-listed (SGX: BVA) TopGlove topped the list10! It is the world’s biggest manufacturer of nitrile gloves, with exports to over 195 countries. Nitrile gloves differ from latex gloves in that they are latex-free.
Q2 2020 revenue was up 50.72% from last year’s levels11. This was contributed by the mass production of face masks from April 2020 onwards on the back of increased demand for personal protective equipment (PPE). PPE includes not only latex gloves but also facial masks.
Demand for both is unlikely to subside anytime soon. Backed by continued expansion of its own supply chain and delivery systems, revenue and growth look set to increase further in the near future.
Price charts of Supermax Corporation Berhad and TopGlove Corporation Berhad
To sum up
As COVID-19 continues to buffet economies and companies worldwide, glove makers are expected to remain popular. Existing players are already working 24/7 to cater to demand.
Interested to invest or trade on the Malaysian market?
Enjoy low brokerage rates from 0.12% and *1-year free digital subscription of ‘The Edge Malaysia’ when you trade Malaysian shares through POEMS. Terms and conditions apply.
Refer to details here.
Have personal views on the above companies? Join our global Telegram investment community and leave us your comments!
Reference:
- [1] http://bintai.com.my/?page_id=562
- [2] https://www.globenewswire.com/news-release/2020/09/18/2095876/0/en/Generex-Signs-Binding-Licensing-Research-Agreement-with-Bintai-Kinden-to-Advance-the-Clinical-Development-Commercialization-of-Ii-Key-SARS-CoV-2-Coronavirus-Vaccine-for-Malaysia.html
- [3] https://www.bursamalaysia.com/trade/trading_resources/listing_directory/company-profile?stock_code=0010
- [4] https://www.theedgemarkets.com/article/iris-corp-receives-loi-indian-epassport-job-worth-us28m
- [5] https://www.theedgemarkets.com/article/jcy-international-scaling-automotive-business
- [6] https://www.jcyinternational.com/images/Report/Interim-Financial-Statements—2020Q2.pdf
- [7] https://www.reuters.com/companies/JCYI.KL
- [8] http://www.supermax.com.my/html/corporate_info.aspx?ID=110&PID=111
- [9] http://www.supermax.com.my/html/annual_reports.aspx
- [10] http://www.supermax.com.my/html/analysts_reports.aspx
- [11] https://www.topglove.com/corporate-profile/
- [12] https://www.topglove.com/financial-information/
Disclaimer
These commentaries are intended for general circulation. It does not have regard to the specific investment objectives, financial situation and particular needs of any person who may receive this document. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of the units and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. Investors may wish to seek advice from a financial adviser before investing. In the event that investors choose not to seek advice from a financial adviser, they should consider whether the investment is suitable for them.
The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.
Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.
About the author
Clement Chua
Equities Dealer
Clement is a dealer for the Global Markets Team focusing on the day markets. He graduated from Monash University with a Bachelor of Business, majoring in Banking and Finance.
Back in Business: The Return of IPOs & Top Traded Counters in March 2024 
From $50 to $100: Unveiling the Impact of Inflation 
How to soar higher with Positive Carry! 
Why 2024 Offers A Small Window of Opportunity and How to Position Yourself to Capture It 
